The systemic effect observed in the BMAL1−/− model differed significantly from that in ApoE−/−, indicating that presumably the Bmal1−/− mice are less prone to the development of atherosclerosis compared to the dyslipidemic ApE−/− mice. This evidence concerns the gene BMAL1 and atherosclerosis.